Spinal cord stimulation (SCS) measurably decreased pain and reduced motor symptoms of Parkinson’s disease, both as a singular therapy and as a “salvage therapy” after deep brain stimulation (DBS) therapies were ineffective, according to researchers from the United States and Japan, in Bioelectronic Medicine.

In the study, first author Krishnan Chakravarthy, MD, PhD, assistant professor of anesthesiology at University of California San Diego School of Medicine, and colleagues recruited 15 patients with Parkinson’s disease (mean age 74), with an average disease duration of 17 years.

All of the patients were experiencing pain not alleviated by previous treatments. Eight had undergone earlier DBS, and seven patients had received only drug treatments previously, according to a media release from UC San Diego.

Researchers implanted percutaneous electrodes near the patients’ spines, who then chose one of three types of electrical stimulation: continuous, on-off bursts or continuous bursts of varying intensity.

Patients Reported Significant Improvement

Following continuous programmed treatment post-implantation, the researchers said all patients reported significant improvement, based on the Visual Analogue Scale, a measurement of pain intensity, with a mean reduction of 59% across all patients and stimulation modes.

Seventy-three percent of patients showed improvement in the 10-meter walk, a test that measures walking speed to assess functional mobility and gait, with an average improvement of 12%.

And 64% of patients experienced improvements in the Timed Up and Go (TUG) test, which measures how long it takes a person to rise from a chair, walk three meters, turn around, walk back to the chair and sit down. TUG assesses physical balance and stability, both standing and in motion. Average TUG improvement was 21%.

The findings suggest SCS may have therapeutic benefit for patients with Parkinson’s in terms of treatment for pain and motor symptoms, the authors suggest, noting that further studies are needed to determine whether improved motor function is due to neurological changes caused by SCS or simply decreased pain.

“We are seeing growing data on novel uses of spinal cord stimulation and specific waveforms on applications outside of chronic pain management, specifically Parkinson’s disease.

“The potential ease of access and implantation of stimulators in the spinal cord compared to the brain suggests that this is a very exciting area for future exploration.”

— Krishnan Chakravarthy, MD, PhD, pain management specialist at UC San Diego Health

[Source(s): University of California – San Diego, Science Daily]

Related Content:
Stem Cells Aim to Repair Parkinson’s-Damaged Circuits in Mouse Brains
Parkinson’s Foundation Expands Its Virtual Programs to Ensure Access to Resources During Pandemic
Michael J. Fox Foundation Relaunches Monthly Parkinson’s Podcast